Costs of treating type 2 diabetes mellitus and its complications

IF 1.5 4区生物学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Biotechnology & Biotechnological Equipment Pub Date : 2024-09-09 DOI:10.1080/13102818.2024.2399941

Nemanja Petrović, Miloš Milosavljević, Refet Gojak, Miralem Đešević, Dragana Lakić, Ivana Stević, Slobodan Janković

引用次数: 0

Abstract

The major driver of the costs of treating patients with diabetes mellitus type 2 (DM2) is its complications, which in developing countries are a consequence of poor glycemic control due to the low ...

查看原文本刊更多论文

治疗 2 型糖尿病及其并发症的费用

2型糖尿病（DM2）患者治疗费用的主要驱动因素是其并发症，在发展中国家，并发症是由于低血糖导致血糖控制不佳的后果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Biotechnology & Biotechnological Equipment 工程技术-生物工程与应用微生物

CiteScore

3.10

自引率

0.00%

发文量

审稿时长

1 months

期刊介绍： Biotechnology & Biotechnological Equipment (B&BE) is an international open access journal publishing cutting-edge research. A modern world requires modern biotechnology and nanobiology. The journal is a forum that provides society with valuable information for a healthy and better life and promotes “the Science and Culture of Nature”. The journal publishes original research and reviews with a multidisciplinary perspective; expanded case reports with a focus on molecular medical research and advanced practice in evidence-based medicine are also considered.